Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misoprostol: discovery, development, and clinical applications.

P W Collins1

  • 1G.D. Searle & Company, Skokie, Illinois 60077.

Medicinal Research Reviews
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early viscoelastometric guided fibrinogen replacement combined with escalation of clinical care reduces progression in postpartum haemorrhage: a comparison of outcomes from two prospective observational studies.

International journal of obstetric anesthesia·2024
Same author

A description of the coagulopathy characteristics in amniotic fluid embolism: a case report.

International journal of obstetric anesthesia·2022
Same author

Corrigendum to "The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort study" [Int J Obstet Anesth. 2021;47:102983].

International journal of obstetric anesthesia·2022
Same author

Comparison of haematological indices and transfusion management in severe and massive postpartum haemorrhage: analysis of a two-year national prospective observational study.

International journal of obstetric anesthesia·2022
Same author

The sensitivity and specificity of rotational thromboelastometry (ROTEM) to detect coagulopathy during moderate and severe postpartum haemorrhage: a prospective observational study.

International journal of obstetric anesthesia·2021
Same author

Utility of viscoelastography with TEG 6s to direct management of haemostasis during obstetric haemorrhage: a prospective observational study.

International journal of obstetric anesthesia·2021

Misoprostol, a synthetic prostaglandin, effectively heals gastric and duodenal ulcers, showing results comparable to H2 receptor antagonists. It also prevents NSAID-induced gastropathy, offering mucosal protection with minimal side effects like mild diarrhea.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Misoprostol is a synthetic prostaglandin E1 analog.
  • It is the first prostaglandin registered for peptic ulcer disease treatment.
  • It exhibits potent gastric antisecretory and mucosal protective effects.

Purpose of the Study:

  • To evaluate misoprostol's efficacy in healing gastric and duodenal ulcers.
  • To assess its effectiveness in preventing NSAID-induced gastropathy.
  • To explore its potential advantages in specific patient populations.

Main Methods:

  • Clinical trials comparing misoprostol (800 micrograms daily) to placebo and H2 receptor antagonists.
  • Assessment of ulcer healing rates in gastric and duodenal ulcer patients.
  • Evaluation of adverse effects, primarily diarrhea.

Related Experiment Videos

Main Results:

  • Misoprostol demonstrated significantly superior complete ulcer healing rates compared to placebo.
  • Healing rates were comparable to those achieved with H2 receptor antagonists.
  • Diarrhea occurred in about 10% of patients, generally mild and self-limiting.

Conclusions:

  • Misoprostol is a safe and effective treatment for peptic ulcers and NSAID-induced gastropathy.
  • Its mucosal protective properties offer potential benefits in compromised patients and refractory cases.
  • Further therapeutic applications for its tissue-protective effects may exist.